Drugs / H9N2 (6-2) AA ca Reassortant
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00110279 | Jun → Sep 2005 | influenza | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | H9N2 (6-2) AA ca Reassortant | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00110279 ↗ |
| Route | Intranasal | “administered intranasally” NCT00110279 ↗ |